EV/EBITDA Ratio: 12.99x
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 12.99x is 46% below its 5-year average of 24.01x, near the low end of its 5-year range (11.92x–39.82x).
As of Friday, June 26, 2026. 28.50% below its 12-month average of 18.17x.
RMD EV/EBITDA Ratio Chart
RMD Average EV/EBITDA Ratio Chart
RMD Current vs Average EV/EBITDA Ratio Chart
RMD EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
12.99x
EV/EBITDA RATIO AVG TTM
18.17x
EV/EBITDA RATIO AVG 3Y
20.02x
EV/EBITDA RATIO AVG 5Y
24.01x
EV/EBITDA RATIO AVG 10Y
24.18x
EV/EBITDA RATIO AVG 15Y
21.56x
EV/EBITDA RATIO AVG 20Y
20.64x
CURRENT VS TTM AVG
-28.50%
CURRENT VS 3Y AVG
-35.12%
CURRENT VS 5Y AVG
-45.89%
CURRENT VS 10Y AVG
-46.27%
CURRENT VS 15Y AVG
-39.74%
CURRENT VS 20Y AVG
-37.05%
RMD Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $28.81B | 12.99x | 18.17x | 20.02x | 24.01x |
| Biogen Inc. (BIIB)vs › | $29.82B | 12.27x | 8.87x | 11.18x | 12.21x |
| IQVIA Holdings Inc. (IQV)vs › | $31.12B | 13.01x | 13.63x | 15.05x | 17.06x |
| DexCom, Inc. (DXCM)vs › | $26.49B | 18.49x | 24.78x | 41.66x | 69.99x |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 18.81x | 32.42x | 43.46x | 53.37x |
| Medline Inc. (MDLN)vs › | $31.94B | 15.22x | 16.10x | 16.10x | 16.10x |
| Centene Corp. (CNC)vs › | $31.98B | N/A | 4.99x | 7.28x | 9.49x |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 21.87x | 23.50x | 23.82x | 26.37x |
| Zoetis Inc. (ZTS)vs › | $32.62B | 9.97x | 15.30x | 20.50x | 23.58x |
| Waters Corporation (WAT)vs › | $24.57B | 39.01x | 22.27x | 21.51x | 21.55x |
EV/EBITDA vs. its own history
At 13.0, EV/EBITDA is cheaper than usual, sitting higher than 4% of its 20-year history.
20-year low
10.1
median
19.7
20-year high
39.8
EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for ResMed Inc. (RMD)?
- The EV/EBITDA ratio for RMD stock is 12.99x.
- Is ResMed Inc.'s EV/EBITDA ratio high or low?
- The EV/EBITDA ratio of 12.99x is 46% below its 5-year average of 24.01x, near the low end of its 5-year range (11.92x–39.82x).
- What is the TTM average EV/EBITDA ratio for ResMed Inc. (RMD)?
- The TTM average EV/EBITDA ratio for RMD stock is 18.17x.
- What is the 3Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
- The 3Y average EV/EBITDA ratio for RMD stock is 20.02x.
- What is the 5Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
- The 5Y average EV/EBITDA ratio for RMD stock is 24.01x.
- What is the 10Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
- The 10Y average EV/EBITDA ratio for RMD stock is 24.18x.
- What is the 15Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
- The 15Y average EV/EBITDA ratio for RMD stock is 21.56x.
- What is the 20Y average EV/EBITDA ratio for ResMed Inc. (RMD)?
- The 20Y average EV/EBITDA ratio for RMD stock is 20.64x.
RMD EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-25 | 12.99x |
| 2026-06-24 | 12.85x |
| 2026-06-23 | 12.49x |
| 2026-06-22 | 12.30x |
| 2026-06-18 | 12.32x |
| 2026-06-17 | 12.16x |
| 2026-06-16 | 12.67x |
| 2026-06-15 | 12.59x |
| 2026-06-12 | 12.73x |
| 2026-06-11 | 12.57x |
| 2026-06-10 | 12.65x |
| 2026-06-09 | 12.87x |
| 2026-06-08 | 12.62x |
| 2026-06-05 | 12.81x |
| 2026-06-04 | 12.70x |
| 2026-06-03 | 12.17x |
| 2026-06-02 | 11.92x |
| 2026-06-01 | 12.17x |
| 2026-05-29 | 12.45x |
| 2026-05-28 | 13.31x |
| 2026-05-27 | 13.49x |
| 2026-05-26 | 13.62x |
| 2026-05-22 | 13.62x |
| 2026-05-21 | 13.68x |
| 2026-05-20 | 13.74x |
| 2026-05-19 | 13.60x |
| 2026-05-18 | 13.36x |
| 2026-05-15 | 13.21x |
| 2026-05-14 | 13.25x |
| 2026-05-13 | 13.24x |
| 2026-05-12 | 13.34x |
| 2026-05-11 | 13.00x |
| 2026-05-08 | 13.54x |
| 2026-05-07 | 13.54x |
| 2026-05-06 | 13.73x |
| 2026-05-05 | 13.61x |
| 2026-05-04 | 13.71x |
| 2026-05-01 | 13.42x |
| 2026-04-30 | 14.01x |
| 2026-04-29 | 14.84x |
| 2026-04-28 | 15.21x |
| 2026-04-27 | 15.56x |
| 2026-04-24 | 15.40x |
| 2026-04-23 | 15.38x |
| 2026-04-22 | 15.56x |
| 2026-04-21 | 15.50x |
| 2026-04-20 | 15.85x |
| 2026-04-17 | 15.99x |
| 2026-04-16 | 15.75x |
| 2026-04-15 | 16.04x |
| 2026-04-14 | 16.17x |
| 2026-04-13 | 16.14x |
| 2026-04-10 | 16.04x |
| 2026-04-09 | 15.98x |
| 2026-04-08 | 16.17x |
| 2026-04-07 | 15.84x |
| 2026-04-06 | 15.76x |
| 2026-04-02 | 15.70x |
| 2026-04-01 | 15.62x |
| 2026-03-31 | 15.73x |
| 2026-03-30 | 15.42x |
| 2026-03-27 | 15.45x |
| 2026-03-26 | 15.59x |
| 2026-03-25 | 15.86x |
| 2026-03-24 | 16.00x |
| 2026-03-23 | 15.98x |
| 2026-03-20 | 15.84x |
| 2026-03-19 | 15.94x |
| 2026-03-18 | 15.97x |
| 2026-03-17 | 16.37x |
| 2026-03-16 | 16.17x |
| 2026-03-13 | 16.18x |
| 2026-03-12 | 16.30x |
| 2026-03-11 | 16.84x |
| 2026-03-10 | 17.34x |
| 2026-03-09 | 17.75x |
| 2026-03-06 | 17.75x |
| 2026-03-05 | 17.92x |
| 2026-03-04 | 18.19x |
| 2026-03-03 | 18.13x |
| 2026-03-02 | 18.07x |
| 2026-02-27 | 17.99x |
| 2026-02-26 | 18.04x |
| 2026-02-25 | 17.72x |
| 2026-02-24 | 17.66x |
| 2026-02-23 | 18.31x |
| 2026-02-20 | 18.19x |
| 2026-02-19 | 17.99x |
| 2026-02-18 | 18.18x |
| 2026-02-17 | 17.96x |
| 2026-02-13 | 17.72x |
| 2026-02-12 | 17.24x |
| 2026-02-11 | 18.23x |
| 2026-02-10 | 18.50x |
| 2026-02-09 | 19.39x |
| 2026-02-06 | 19.08x |
| 2026-02-05 | 18.75x |
| 2026-02-04 | 18.47x |
| 2026-02-03 | 17.64x |
| 2026-02-02 | 17.88x |
| 2026-01-30 | 18.13x |
| 2026-01-29 | 18.08x |
| 2026-01-28 | 18.83x |
| 2026-01-27 | 18.66x |
| 2026-01-26 | 18.66x |
| 2026-01-23 | 18.43x |
| 2026-01-22 | 18.65x |
| 2026-01-21 | 18.94x |
| 2026-01-20 | 18.49x |
| 2026-01-16 | 18.82x |
| 2026-01-15 | 19.05x |
| 2026-01-14 | 18.96x |
| 2026-01-13 | 18.60x |
| 2026-01-12 | 18.84x |
| 2026-01-09 | 18.44x |
| 2026-01-08 | 18.32x |
| 2026-01-07 | 18.12x |
| 2026-01-06 | 18.19x |
| 2026-01-05 | 17.91x |
| 2026-01-02 | 17.87x |
| 2025-12-31 | 17.58x |
| 2025-12-30 | 17.74x |
| 2025-12-29 | 17.72x |
| 2025-12-26 | 17.87x |
| 2025-12-24 | 17.84x |
| 2025-12-23 | 17.85x |
| 2025-12-22 | 18.01x |
| 2025-12-19 | 17.88x |
| 2025-12-18 | 17.70x |
| 2025-12-17 | 17.95x |
| 2025-12-16 | 18.06x |
| 2025-12-15 | 18.48x |
| 2025-12-12 | 18.42x |
| 2025-12-11 | 18.43x |
| 2025-12-10 | 18.37x |
| 2025-12-09 | 18.00x |
| 2025-12-08 | 18.26x |
| 2025-12-05 | 18.74x |
| 2025-12-04 | 18.37x |
| 2025-12-03 | 18.36x |
| 2025-12-02 | 18.32x |
| 2025-12-01 | 18.13x |
| 2025-11-28 | 18.69x |
| 2025-11-26 | 18.63x |
| 2025-11-25 | 18.68x |
| 2025-11-24 | 18.29x |
| 2025-11-21 | 18.31x |
| 2025-11-20 | 17.80x |
| 2025-11-19 | 17.88x |
| 2025-11-18 | 17.97x |
| 2025-11-17 | 17.86x |
| 2025-11-14 | 17.84x |
| 2025-11-13 | 18.41x |
| 2025-11-12 | 18.47x |
| 2025-11-11 | 18.43x |
| 2025-11-10 | 18.26x |
| 2025-11-07 | 18.37x |
| 2025-11-06 | 18.23x |
| 2025-11-05 | 17.90x |
| 2025-11-04 | 17.99x |
| 2025-11-03 | 18.18x |
| 2025-10-31 | 18.02x |
| 2025-10-30 | 18.42x |
| 2025-10-29 | 19.20x |
| 2025-10-28 | 19.43x |
| 2025-10-27 | 19.63x |
| 2025-10-24 | 19.65x |
| 2025-10-23 | 20.09x |
| 2025-10-22 | 20.18x |
| 2025-10-21 | 20.32x |
| 2025-10-20 | 20.56x |
| 2025-10-17 | 20.31x |
| 2025-10-16 | 20.45x |
| 2025-10-15 | 20.43x |
| 2025-10-14 | 20.46x |
| 2025-10-13 | 20.68x |
| 2025-10-10 | 20.60x |
| 2025-10-09 | 21.05x |
| 2025-10-08 | 21.40x |
| 2025-10-07 | 21.47x |
| 2025-10-06 | 21.32x |
| 2025-10-03 | 21.11x |
| 2025-10-02 | 20.96x |
| 2025-10-01 | 20.52x |
| 2025-09-30 | 20.74x |
| 2025-09-29 | 20.53x |
| 2025-09-26 | 20.47x |
| 2025-09-25 | 20.25x |
| 2025-09-24 | 20.77x |
| 2025-09-23 | 20.88x |
| 2025-09-22 | 20.79x |
| 2025-09-19 | 20.70x |
| 2025-09-18 | 20.70x |
| 2025-09-17 | 20.58x |
| 2025-09-16 | 20.65x |
| 2025-09-15 | 20.54x |
| 2025-09-12 | 20.46x |
| 2025-09-11 | 20.80x |
| 2025-09-10 | 20.49x |
| 2025-09-09 | 21.15x |
| 2025-09-08 | 21.17x |
| 2025-09-05 | 20.99x |
| 2025-09-04 | 20.74x |
| 2025-09-03 | 20.39x |
| 2025-09-02 | 20.53x |
| 2025-08-29 | 20.80x |
| 2025-08-28 | 20.86x |
| 2025-08-27 | 21.37x |
| 2025-08-26 | 21.61x |
| 2025-08-25 | 21.66x |
| 2025-08-22 | 22.27x |
| 2025-08-21 | 21.85x |
| 2025-08-20 | 21.91x |
| 2025-08-19 | 21.68x |
| 2025-08-18 | 21.68x |
| 2025-08-15 | 21.59x |
| 2025-08-14 | 21.58x |
| 2025-08-13 | 21.85x |
| 2025-08-12 | 21.47x |
| 2025-08-11 | 21.55x |
| 2025-08-08 | 21.51x |
| 2025-08-07 | 21.23x |
| 2025-08-06 | 23.49x |
| 2025-08-05 | 23.87x |
| 2025-08-04 | 24.41x |
| 2025-08-01 | 23.39x |
| 2025-07-31 | 22.78x |
| 2025-07-30 | 23.24x |
| 2025-07-29 | 23.26x |
| 2025-07-28 | 22.91x |
| 2025-07-25 | 23.05x |
| 2025-07-24 | 22.91x |
| 2025-07-23 | 22.90x |
| 2025-07-22 | 22.40x |
| 2025-07-21 | 21.86x |
| 2025-07-18 | 21.60x |
| 2025-07-17 | 21.47x |
| 2025-07-16 | 21.29x |
| 2025-07-15 | 21.10x |
| 2025-07-14 | 21.28x |
| 2025-07-11 | 21.30x |
| 2025-07-10 | 21.61x |
| 2025-07-09 | 21.44x |
| 2025-07-08 | 21.49x |
| 2025-07-07 | 21.47x |
| 2025-07-03 | 21.52x |
| 2025-07-02 | 21.43x |
| 2025-07-01 | 21.46x |
| 2025-06-30 | 21.61x |
| 2025-06-27 | 21.37x |
| 2025-06-26 | 21.46x |
| 2025-06-25 | 21.60x |
| 2025-06-24 | 21.43x |
| 2025-06-23 | 21.31x |
| 2025-06-20 | 21.24x |
| 2025-06-18 | 21.01x |
| 2025-06-17 | 20.94x |
| 2025-06-16 | 21.08x |
| 2025-06-13 | 20.88x |
| 2025-06-12 | 21.12x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell